fidaxomicin April 12, 2017 fidaxomicin Trade Name Dificid Orphan Indication Pediatric Clostridium difficile infection USA Market Approval USA USA Designation Date 2010-12-13 00:00:00 Sponsor Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc.;20 Weystrasse;Luzern
